SPL 1.08% 9.4¢ starpharma holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12

  1. WBA
    2,333 Posts.
    lightbulb Created with Sketch. 413
    2022/23 Full year shows;

    Receipts (products and royalties)- 3.085m (21/22 $4.846m) DOWN 1.76m
    Product manufacturing and operating costs (products) - 4.097m ( 21/22 - $4.84m) - UP 743,000
    Research and Development - 10.152m (21/22 - 10.54m) - UP - 388,000

    Appears we are holding a very large inventory (2.824m FY 21/22) and 2.817 at 22/12/22, product manufacturing up and revenue down.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $39.02M
Open High Low Value Volume
9.4¢ 9.5¢ 9.3¢ $29.74K 318.9K

Buyers (Bids)

No. Vol. Price($)
1 149315 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 1370 1
View Market Depth
Last trade - 15.59pm 13/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.